Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Yogesh Suresh Ahire"'
Autor:
Deepak Devidas Sonawane, Ashish Y. Pawar, Yogesh Suresh Ahire, Apoorva Prashant Hiray, Rajendra Sudhakar Bhambar, Deelip V. Derle
Publikováno v:
Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Diabetes & Metabolic Syndrome
Diabetes & Metabolic Syndrome
Background & Aim As on date, no specific treatment is available for devastating COVID-19 (SARS-CoV-2) infection. This pandemic viral infection has affected over 200 countries within a very short time and created a calamitous situationacross the globe
Autor:
Usha Ghosh, Smriti Khanna, Asha Kulkarni-Almeida, Ankita Srivastava, Komal Bajaj, Chandrika B-Rao, Prashant Tannu, Ashish P. Keche, Kumar V.S. Nemmani, Pranay Shah, Sandeep Burudkar, Rajiv Sharma, Yogesh Suresh Ahire, H. Sivaramakrishnan, Amol Dixit, Anagha Damre, Nitin J. Deshmukh
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 23:834-838
We report our attempts at improving the oral efficacy of low-nanomolar inhibitors of xanthine oxidase from isocytosine series through chemical modifications. Our lead compound had earlier shown good in vivo efficacy when administered intraperitoneall
Publikováno v:
Indian Journal of Pharmaceutical Sciences
In type 2 Diabetes, oxidative stress plays an important role in development and aggregation of insulin resistance. In the present study, long term administration of the dexamethasone led to the development of insulin resistance in mice. The effect of
Publikováno v:
Inflammopharmacology. 18(4)
The present study was planned to investigate the antioxidant, antinociceptive, and anti-inflammatory activities of atorvastatin and rosuvastatin (1, 3 and 10 mg/kg, p.o.) in various animal models. The antinociceptive effect was assessed by chemically
Publikováno v:
Chronicles of Young Scientists, Vol 4, Iss 1, Pp 59-68 (2013)
Aim: Effect of PPAR-g agonists, Thiazolidinediones, in combination with melatonin was studied for cardiovascular complications associated with diabetes. Materials and Methods: Diabetic rats were treated with combination of pioglitazone (10 mg/kg/day